Works by Dumez, H.

Results: 14

Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of the novel anticancer agent E7070 in four phase I studies.
Published in:
2002
By:
- van Kesteren, CH;
- Mathôt, R. A. A;
- Raymond, E;
- Armand, J. P;
- Dittrich, CH;
- Dumez, H;
- Roché, H;
- Droz, J. P;
- Punt, C;
- Ravic, M;
- Wanders, J;
- Beijnen, J. H;
- Fumoleau, P;
- Schellens, J. H. M
Publication type:
Abstract
Quantitation of suspensions (MESED). Application of MESED-gC/MS in the quantitation of ifosfamide mustard in erythrocytes, plasma, and plasma water.
Published in:
Journal of Separation Science, 2001, v. 24, n. 2, p. 123, doi. 10.1002/1615-9314(20010201)24:2<123::AID-JSSC123>3.0.CO;2-8
By:
- Dumez, H.;
- Guetens, G.;
- De Boeck, G.;
- Highley, M.;
- Tjaden, U. R.;
- Maes, R.;
- Hanauske, A.;
- Van Oosterom, A. T.;
- de Bruijn, E. A.
Publication type:
Article
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Published in:
2018
By:
- van Cann, T.;
- Loyson, T.;
- Verbiest, A.;
- Clement, P. M.;
- Bechter, O.;
- Willems, L.;
- Spriet, I.;
- Coropciuc, R.;
- Politis, C.;
- Vandeweyer, R. O.;
- Schoenaers, J.;
- Debruyne, P. R.;
- Dumez, H.;
- Berteloot, P.;
- Neven, P.;
- Nackaerts, K.;
- Woei-A-Jin, F. J. S. H.;
- Punie, K.;
- Wildiers, H.;
- Beuselinck, B.
Publication type:
journal article
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases.
Published in:
British Journal of Cancer, 2012, v. 107, n. 10, p. 1665, doi. 10.1038/bjc.2012.385
By:
- Beuselinck, B;
- Wolter, P;
- Karadimou, A;
- Elaidi, R;
- Dumez, H;
- Rogiers, A;
- Van Cann, T;
- Willems, L;
- Body, J-J;
- Berkers, J;
- Van Poppel, H;
- Lerut, E;
- Debruyne, P;
- Paridaens, R;
- Schöffski, P
Publication type:
Article
The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation.
Published in:
2008
By:
- Wolter, P.;
- Stefan, C.;
- Decallonne, B.;
- Dumez, H.;
- Bex, M.;
- Carmeliet, P.;
- Schöffski, P.;
- Schöffski, P
Publication type:
journal article
A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours.
Published in:
British Journal of Cancer, 2004, v. 90, n. 12, p. 2261, doi. 10.1038/sj.bjc.6601811
By:
- Wachters, Fm;
- Groen, Hjm;
- Maring, Jg;
- Gietema, Jg;
- Porro, M;
- Dumez, H;
- Vries, Ege De;
- Oosterom, AT Van
Publication type:
Article
Phase I study of pulsatile 3-day administration of afatinib (BIBW 2992) in combination with docetaxel in advanced solid tumors.
Published in:
Investigational New Drugs, 2013, v. 31, n. 3, p. 734, doi. 10.1007/s10637-012-9880-0
By:
- Awada, A.;
- Dumez, H.;
- Hendlisz, A.;
- Wolter, P.;
- Besse-Hammer, T.;
- Uttenreuther-Fischer, M.;
- Stopfer, P.;
- Fleischer, F.;
- Piccart, M.;
- Schöffski, P.
Publication type:
Article
Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies.
Published in:
2011
By:
- Schöffski P;
- Dumez H;
- Ruijter R;
- Miguel-Lillo B;
- Soto-Matos A;
- Alfaro V;
- Giaccone G
Publication type:
Journal Article
Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies.
Published in:
Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1397, doi. 10.1007/s00280-011-1612-1
By:
- Schöffski, P.;
- Dumez, H.;
- Ruijter, R.;
- Miguel-Lillo, B.;
- Soto-Matos, A.;
- Alfaro, V.;
- Giaccone, G.
Publication type:
Article
Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis".
Published in:
Sarcoma, 2021, p. 1, doi. 10.1155/2021/4653987
By:
- Schöffski, P.;
- Timmermans, I.;
- Hompes, D.;
- Stas, M.;
- Boecxstaens, Veerle;
- Sinnaeve, F.;
- De Leyn, P.;
- Coosemans, W.;
- Van Raemdonck, D.;
- Hauben, E.;
- Sciot, R.;
- Clement, P.;
- Bechter, O.;
- Beuselinck, B.;
- Woei-A-Jin, F. J. S. H.;
- Dumez, H.;
- Nafteux, P.;
- Wessels, T.
Publication type:
Article
Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis.
Published in:
Sarcoma, 2020, p. 1, doi. 10.1155/2020/1385978
By:
- Schöffski, P.;
- Timmermans, I.;
- Hompes, D.;
- Stas, M.;
- Sinnaeve, F.;
- De Leyn, P.;
- Coosemans, W.;
- Van Raemdonck, D.;
- Hauben, E.;
- Sciot, R.;
- Clement, P.;
- Bechter, O.;
- Beuselinck, B.;
- Woei-A-Jin, F. J. S. H.;
- Dumez, H.;
- Nafteux, P.;
- Wessels, T.
Publication type:
Article
Ecteinascidin-743: evidence of activity in advanced, pretreated soft tissue and bone sarcoma patients.
Published in:
2006
By:
- Huygh G;
- Clement PMJ;
- Dumez H;
- Schöffski P;
- Wildiers H;
- Selleslach J;
- Jimeno JM;
- De Wever I;
- Sciot R;
- Duck L;
- Van Oosterom AT
Publication type:
Journal Article
Ecteinascidin-743: Evidence of Activity in Advanced, Pretreated Soft Tissue and Bone Sarcoma Patients.
Published in:
Sarcoma, 2006, v. 2006, p. 1, doi. 10.1155/SRCM/2006/56282
By:
- Huygh, G.;
- Clement, Paul M. J.;
- Dumez, H.;
- Schöffski, P.;
- Wildiers, H.;
- Selleslach, J.;
- Jimeno, J. M.;
- DeWever, I.;
- Sciot, R.;
- Duck, L.;
- Van Oosterom, A. T.
Publication type:
Article
A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours.
Published in:
British Journal of Cancer, 2000, v. 83, n. 5, p. 594, doi. 10.1054/bjoc.2000.1305
By:
- Paridaens, R;
- Uges, D R A;
- Barbet, N;
- Choi, L;
- Seeghers, M;
- Graaf, W T A van der;
- Groen, H J M;
- Dumez, H;
- Buuren, I Van;
- Muskiet, F;
- Capdeville, R;
- Oosterom, A T van;
- Vries, E G E de
Publication type:
Article